114 related articles for article (PubMed ID: 9634038)
1. Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease.
Stapleton AM; Timme TL; Ryall RL
Br J Urol; 1998 May; 81(5):666-71; discussion 671-2. PubMed ID: 9634038
[TBL] [Abstract][Full Text] [Related]
2. The prothrombin gene is expressed in the rat kidney: Implications for urolithiasis research.
Grover PK; Dogra SC; Davidson BP; Stapleton AM; Ryall RL
Eur J Biochem; 2000 Jan; 267(1):61-7. PubMed ID: 10601851
[TBL] [Abstract][Full Text] [Related]
3. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
4. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
[TBL] [Abstract][Full Text] [Related]
5. Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix.
Stapleton AM; Dawson CJ; Grover PK; Hohmann A; Comacchio R; Boswarva V; Tang Y; Ryall RL
Kidney Int; 1996 Mar; 49(3):880-8. PubMed ID: 8648933
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease.
Ryall RL
Br J Urol; 1998 Jun; 81(6):933-4. PubMed ID: 9666793
[No Abstract] [Full Text] [Related]
7. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
Liu J; Chen J; Wang T; Wang S; Ye Z
J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
[TBL] [Abstract][Full Text] [Related]
8. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation.
Webber D; Radcliffe CM; Royle L; Tobiasen G; Merry AH; Rodgers AL; Sturrock ED; Wormald MR; Harvey DJ; Dwek RA; Rudd PM
FEBS J; 2006 Jul; 273(13):3024-37. PubMed ID: 16817853
[TBL] [Abstract][Full Text] [Related]
9. Synergism between urinary prothrombin fragment 1 and urine: a comparison of inhibitory activities in stone-prone and stone-free population groups.
Webber D; Rodgers AL; Sturrock ED
Clin Chem Lab Med; 2002 Sep; 40(9):930-6. PubMed ID: 12435111
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
Stapleton AM; Ryall RL
Br J Urol; 1995 Jun; 75(6):712-9. PubMed ID: 7613825
[TBL] [Abstract][Full Text] [Related]
11. Expression of heparan sulfate proteoglycan mRNA in rat kidneys during calcium oxalate nephrolithiasis.
Iida S; Miyajima J; Suzuki K; Matsuoka K; Inoue M; Noda S
Urol Res; 1997; 25(5):361-4. PubMed ID: 9373918
[TBL] [Abstract][Full Text] [Related]
12. Multicolor imaging of calcium-binding proteins in human kidney stones for elucidating the effects of proteins on crystal growth.
Tanaka Y; Maruyama M; Okada A; Furukawa Y; Momma K; Sugiura Y; Tajiri R; Sawada KP; Tanaka S; Takano K; Taguchi K; Hamamoto S; Ando R; Tsukamoto K; Yoshimura M; Mori Y; Yasui T
Sci Rep; 2021 Aug; 11(1):16841. PubMed ID: 34446727
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of anti-CD75 reactive proteins on distal and collecting renal tubular epithelial cells in calcium-oxalate stone-forming kidneys in Egypt.
Kramer G; Steiner GE; Neumayer C; Prinz-Kashani M; Hohenfellner M; Gomha M; Ghoneim M; Newman M; Marberger M
BJU Int; 2004 Apr; 93(6):822-6. PubMed ID: 15049997
[TBL] [Abstract][Full Text] [Related]
14. Effects of oxalate exposure on Madin-Darby canine kidney cells in culture: renal prothrombin fragment-1 mRNA expression.
Moryama MT; Domiki C; Miyazawa K; Tanaka T; Suzuki K
Urol Res; 2005 Dec; 33(6):470-5. PubMed ID: 16320015
[TBL] [Abstract][Full Text] [Related]
15. Association between human prothrombin variant (T165M) and kidney stone disease.
Rungroj N; Sudtachat N; Nettuwakul C; Sawasdee N; Praditsap O; Jungtrakoon P; Sritippayawan S; Chuawattana D; Borvornpadungkitti S; Predanon C; Susaengrat W; Yenchitsomanus PT
PLoS One; 2012; 7(9):e45533. PubMed ID: 23029076
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin gene expression in rat kidneys provides an opportunity to examine its role in urinary stone pathogenesis.
Grover PK; Stapleton AM; Ryall RL
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S404-7. PubMed ID: 10541273
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.
Webber D; Rodgers AL; Sturrock ED
Urol Res; 2007 Dec; 35(6):277-85. PubMed ID: 17987287
[TBL] [Abstract][Full Text] [Related]
18. Protein regulation of intrarenal crystallization.
Kumar V; Lieske JC
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):374-80. PubMed ID: 16775451
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis.
Iida S; Inoue M; Yoshii S; Yanagaki T; Chikama S; Shimada A; Matsuoka K; Noda S; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S412-6. PubMed ID: 10541275
[TBL] [Abstract][Full Text] [Related]
20. Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals.
Cook AF; Grover PK; Ryall RL
BJU Int; 2009 Mar; 103(6):826-35. PubMed ID: 19021614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
